Results 1 to 10 of about 48,914 (162)

Anthracyclines [PDF]

WikiJournal of Medicine, 2018
No description ...
Alison Cheong, Sean McGrath, Suzanne Cutts   +2 more
openaire   +2 more sources

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review

Frontiers in Pharmacology, 2020
BackgroundEvidence of the preventive and therapeutic effects of enalapril on cardiotoxicity caused by chemotherapy needs to be further confirmed and updated.MethodsWe performed a systematic review of studies from electronic databases that were searched ...
Yili Zhang, Junjie Liu, Yuan Li, Nannan Tan, Kangjia Du, Huihui Zhao, Huihui Zhao, Juan Wang, Juan Wang, Jian Zhang, Wei Wang, Wei Wang, Yong Wang   +12 more
doaj   +1 more source

Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry

Frontiers in Oncology, 2022
BackgroundDiffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma, standard CHOP was the treatment of choice, 42% of patients received rituximab, and 29% of patients were lost to follow-up during therapy, were reported in a study that ...
Reena Nair, Dinesh Bhurani, Senthil Rajappa, Asha Kapadia, Rakesh Reddy Boya, Subramanian Sundaram, Hari Menon, Ganapathi S. Raman, Arun Seshachalam, Ramesh Nimmagadda   +9 more
doaj   +1 more source

The effects of low‐dose anthracycline‐based chemotherapy on the levels of serum NT‐proBNP level and left ventricular systolic and diastolic dysfunctions: A prospective observational study

Health Science Reports, 2022
Background and Aims The present study aimed to evaluate the relationship between serum N‐terminal (NT)‐pro‐brain natriuretic peptide (BNP) levels and incidence of left ventricular (LV) systolic and diastolic dysfunction in patients who underwent low‐dose
Fatemeh Mohammadi, Leila Bigdelu, Abolghasem Allahyari, Negar Morovatdar, Vafa Baradaran Rahimi   +4 more
doaj   +1 more source

Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer

Translational Oncology
Background: The selection of appropriate chemotherapy backbone agents in combination with neoadjuvant immunotherapy for triple-negative breast cancer (TNBC) remains unclear.
Yuhan Wei, Qiao Li, Hongnan Mo, Yalong Qi, Hewei Ge, Xiaoying Sun, Ying Fan, Pin Zhang, Jiayu Wang, Yang Luo, Jing Wang, Fei Ma   +11 more
doaj   +1 more source

Coronary atherosclerosis and chemotherapy: From bench to bedside

Frontiers in Cardiovascular Medicine, 2023
Cardiovascular disease, particularly coronary artery disease, is the leading cause of death in humans worldwide. Coronary heart disease caused by chemotherapy affects the prognosis and survival of patients with tumors. The most effective chemotherapeutic
Fanghui Zhou, Xinxin Zhu, Yao Liu, Yue Sun, Ying Zhang, Dechun Cheng, Wei Wang   +6 more
doaj   +1 more source

Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis

Frontiers in Pharmacology
BackgroundAnthracyclines are widely used paediatric chemotherapy drugs, but anthracycline-induced cardiotoxicity (ACT) can cause heart failure in 16% of children.
Ling Yin Fritz Wong, Alastair G. Sutcliffe, Carmen Lok Tung Ho, Yan Lu, Carrie L. Williams, Carrie L. Williams, Faiza Afzal, Mitana Purkayastha   +7 more
doaj   +1 more source

Assessment of Subclinical Deterioration of Right Ventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Breast Cancer Patients Undergoing Anthracycline-Based Chemotherapy [Erratum]

International Journal of General Medicine, 2022
Xu H, Mao L, Liu H, Zhang Y, Yang J. Int J Gen Med. 2021;14:885–893. The authors wish to advise of errors with Figures 2 and 3 on page 891. The Figure 3 image belongs with the Figure 2 caption and the Figure 2 image belongs with the Figure 3 ...
Xu H, Mao L, Liu H, Zhang Y, Yang J
doaj  

PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Cancer therapies inhibiting PI3Kα (phosphoinositide 3‐kinase‐α)–dependent growth factor signaling, including trastuzumab inhibition of HER2 (Human Epidermal Growth Factor Receptor 2), can cause adverse effects on the heart.
Brent A. McLean, Vaibhav B. Patel, Pavel Zhabyeyev, Xueyi Chen, Ratnadeep Basu, Faqi Wang, Saumya Shah, Bart Vanhaesebroeck, Gavin Y. Oudit   +8 more
doaj   +1 more source

Age‐Related Long‐Term Longitudinal Changes in Left Ventricular Mechanical Function in Breast Cancer Patients Undergoing Anthracycline and Trastuzumab Treatment

Clinical Case Reports
Age significantly influences the severity of chemotherapy‐induced cardiotoxicity (cardiotoxicity) in HER2‐positive breast cancer patients. Comprehensive cardiac monitoring before, during, and after anthracycline and trastuzumab regimens is essential ...
Begimai Akbalaeva, Priti Singh, Salman Khan   +2 more
doaj   +1 more source